PRA Health Sciences ($PRAH) recruited a healthcare marketing firm with the goal of refining its pitch to potential trial participants and improving recruitment.
DJM PAN Unlimited, a multichannel marketing company, is on board to help PRA with patient education, according to PMLive, developing campaigns designed to make clear the requirements and potential risks involved with taking part in a trial.
DJM PAN, a subsidiary of HealthUnlimited, produces print, television and digital ads for healthcare companies through its offices in London and New York. The company came to be in October, when HealthUnlimited merged the more traditional ad firm DJM with the digital-focused PAN.
PRA has been quickly expanding its global profile since executing a roughly $300 million IPO in late 2014. The company has been adding employees around the world, setting up recruitment platforms targeting nurses, study coordinators and healthcare workers who may thrive as clinical research associates.
The modern PRA came about thanks to private equity firm KKR ($KKR), which won a bidding war and picked up the CRO for $1.3 billion in 2013. A few months later, KKR paid an undisclosed sum for ReSearch Pharmaceutical Services and merged its two acquisitions. By year's end, the company had acquired CRI Lifetree to bolster its piecemeal CRO's early-stage capabilities, completing KKR's buy-and-merge plan.
- read the story